Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Barry

Showing results (641-650 of 674) with videos related to

Pageof 68
Sort By:
Cancer Cell|June 7, 2016
CXCR2 Inhibition Profoundly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal AdenocarcinomaColin W Steele, Saadia A Karim, Joshua D G Leach, et al.
Analytical Chemistry|January 10, 2022
Method To Visualize the Intratumor Distribution and Impact of Gemcitabine in Pancreatic Ductal Adenocarcinoma by Multimodal ImagingNicole Strittmatter, Frances M Richards, Alan M Race, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 8, 2019
The Immune Microenvironment in Hormone Receptor-Positive Breast Cancer Before and After Preoperative ChemotherapyAdrienne G Waks, Daniel G Stover, Jennifer L Guerriero, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 9, 2020
Genomic Characterization of <i>de novo</i> Metastatic Breast CancerAna C Garrido-Castro, Liam F Spurr, Melissa E Hughes, et al.
Cancer Discovery|October 31, 2018
Cells Lacking the <i>RB1</i> Tumor Suppressor Gene Are Hyperdependent on Aurora B Kinase for SurvivalMatthew G Oser, Raquel Fonseca, Abhishek A Chakraborty, et al.
The Lancet. Oncology|March 19, 2019
Olaparib and α-specific PI3K inhibitor alpelisib for patients with epithelial ovarian cancer: a dose-escalation and dose-expansion phase 1b trialPanagiotis A Konstantinopoulos, William T Barry, Michael Birrer, et al.
Science Translational Medicine|February 12, 2016
Aurora kinase inhibitor nanoparticles target tumors with favorable therapeutic index in vivoSusan Ashton, Young Ho Song, Jim Nolan, et al.
Eneurologicalsci|September 1, 2023
Ischemic strokes revealing neurosyphilis: Study of six (6) observations at the neurology Department of the University Hospital of ConakryM L Touré, T H Baldé, M S Diallo, et al.
Molecular Cancer Therapeutics|April 15, 2026
Targeting the chromatin modifying enzyme, KDM5C, enhances AKT inhibition response in ER+ breast cancerValentina Cutano, Shanade Dunn, Sungmi Park-Chouinard, et al.
Journal of the National Cancer Institute|August 10, 2020
Serial Analysis of Circulating Tumor Cells in Metastatic Breast Cancer Receiving First-Line ChemotherapyMark Jesus M Magbanua, Laura H Hendrix, Terry Hyslop, et al.
Pageof 68

Showing results (641-650 of 674) with videos related to

Sort By:
Pageof 68
Cancer Cell|June 7, 2016
CXCR2 Inhibition Profoundly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal AdenocarcinomaColin W Steele, Saadia A Karim, Joshua D G Leach, et al.
Analytical Chemistry|January 10, 2022
Method To Visualize the Intratumor Distribution and Impact of Gemcitabine in Pancreatic Ductal Adenocarcinoma by Multimodal ImagingNicole Strittmatter, Frances M Richards, Alan M Race, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 8, 2019
The Immune Microenvironment in Hormone Receptor-Positive Breast Cancer Before and After Preoperative ChemotherapyAdrienne G Waks, Daniel G Stover, Jennifer L Guerriero, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 9, 2020
Genomic Characterization of <i>de novo</i> Metastatic Breast CancerAna C Garrido-Castro, Liam F Spurr, Melissa E Hughes, et al.
Cancer Discovery|October 31, 2018
Cells Lacking the <i>RB1</i> Tumor Suppressor Gene Are Hyperdependent on Aurora B Kinase for SurvivalMatthew G Oser, Raquel Fonseca, Abhishek A Chakraborty, et al.
The Lancet. Oncology|March 19, 2019
Olaparib and α-specific PI3K inhibitor alpelisib for patients with epithelial ovarian cancer: a dose-escalation and dose-expansion phase 1b trialPanagiotis A Konstantinopoulos, William T Barry, Michael Birrer, et al.
Science Translational Medicine|February 12, 2016
Aurora kinase inhibitor nanoparticles target tumors with favorable therapeutic index in vivoSusan Ashton, Young Ho Song, Jim Nolan, et al.
Eneurologicalsci|September 1, 2023
Ischemic strokes revealing neurosyphilis: Study of six (6) observations at the neurology Department of the University Hospital of ConakryM L Touré, T H Baldé, M S Diallo, et al.
Molecular Cancer Therapeutics|April 15, 2026
Targeting the chromatin modifying enzyme, KDM5C, enhances AKT inhibition response in ER+ breast cancerValentina Cutano, Shanade Dunn, Sungmi Park-Chouinard, et al.
Journal of the National Cancer Institute|August 10, 2020
Serial Analysis of Circulating Tumor Cells in Metastatic Breast Cancer Receiving First-Line ChemotherapyMark Jesus M Magbanua, Laura H Hendrix, Terry Hyslop, et al.
Pageof 68